Darier Disease Drugs Market by Product and Geography - Forecast and Analysis 2022-2026

Published: Jul 2022

Pages: 121

SKU: IRTNTR73887

Snapshot

The darier disease drugs market share is expected to increase to USD 45.37 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 4.6%.

This darier disease drugs market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers darier disease drugs market segmentation by product (topical retinoids, oral retinoids, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). The darier disease drugs market report also offers information on several market vendors, including AbbVie Inc., Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., BridgeBio Pharma Inc., Galderma SA, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Johnson and Johnson, Laminar Pharma, Mayne Pharma Group Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sawai Pharmaceutical Co. Ltd., Sigmapharm Laboratories LLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Tolmar Pharmaceuticals Inc., Validus Pharmaceuticals LLC, and Viatris Inc. among others.

What will the Darier Disease Drugs Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Darier Disease Drugs Market Size for the Forecast Period and Other Important Statistics

Darier Disease Drugs Market: Key Drivers, Trends, and Challenges

The increase in demand for advanced dermatological diagnosis is notably driving the darier disease drugs market growth, although factors such as the lack of awareness among patients may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the darier disease drugs industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Darier Disease Drugs Market Driver

The increase in demand for advanced dermatological diagnosis is one of the key drivers supporting the darier disease drugs market growth.
The introduction of dermatoscopy to diagnose skin conditions such as darier disease has simplified the diagnostic approach and enabled the ease of drugs for physicians.
Technological advancements in the field of dermatological diagnosis are focused on enhancing the accuracy and sensitivity of the detection mechanisms.
Surgical treatment of darier disease includes dermabrasion, electrosurgery, and MOHS micrographic surgery. However, recent advances with the use of lasers give positive outcomes of remission for up to two years. Such advancements will drive the darier disease drugs market growth during the forecast period.

Key Darier Disease Drugs Market Trend

Increasing research on gene therapy is one of the key darier disease drugs market trends contributing to the market growth.
Gene therapy has been used for the treatment of many dermatological conditions, such as darier disease.
Gene therapies are highly regulated by regulatory bodies such as the National Institutes of Health (NIH) and the Food and Drug Administration (FDA).
The main challenge of gene therapy is that the effects are short-lived. However, the advancements in molecular characterization of dermatological conditions have led to a better understanding of the pathogenetic processes underlying skin diseases. This factor is propelling the market growth.

Key Darier Disease Drugs Market Challenge

Lack of awareness among patients is one of the factors hampering the darier disease drugs market growth.
Dermatological conditions such as darier disease can lower a patient's self-esteem and create negative self-perceptions in the patient about one body image.
Patient perception of therapy cost is also a key barrier to availing of therapy. Moreover, the physician can also provide information about the overall cost of treatment, including copays and prior drug authorization, which can be a constraint for patients to opt for dermatological medications.
Successful patient education is a key strategy for improving patient perception.
Significantly, educating physicians to improve both their knowledge about dermatological diseases and the skills required in the assessment and management of dermatological diseases is a critical factor. Such criticality may hamper the market growth during the forecast period.

This darier disease drugs market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global darier disease drugs market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the darier disease drugs market during the forecast period.

Who are the Major Darier Disease Drugs Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

This statistical study of the darier disease drugs market encompasses successful business strategies deployed by the key vendors. The darier disease drugs market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Product Insights and News

Bausch.com - The company offers darier disease drugs such as Altreno, Arazlo.
Bridgebio.com - The company offers darier disease drug namely BBP 561.
Galderma.com - The company offers darier disease drug namely Soolantra.

To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The darier disease drugs market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Darier Disease Drugs Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the darier disease drugs market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Darier Disease Drugs Market?

For more insights on the market share of various regions Request for a FREE sample now!

40% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for the darier disease drugs market in North America. Market growth in this region will be faster than the growth of the market in Asia and Europe.

The growing awareness of diagnostic dermatology tests among people will facilitate the darier disease drugs market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The COVID-19 outbreak negatively impacted the darier disease drugs market in the region in 2020. However, the initiation of large-scale COVID-19 vaccination drives from December 2020 and the subsequent lifting of lockdown restrictions led to the gradual resumption of operations at manufacturing and logistics units for darier drugs, which resulted in the ease of R&D-related constraints. Thus, the gradually improving economic situation in North America will drive the growth of the regional darier disease drugs market during the forecast period.

What are the Revenue-generating Product Segments in the Darier Disease Drugs Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The darier disease drugs market share growth by the topical retinoids segment will be significant during the forecast period. Topical retinoids are a class of medications that are chemically derived from vitamin A and regulate numerous transcription factors located within the nucleus of various cells. It also contributes greatly to intercellular communication, allowing signaling to nearby cells by binding to nuclear receptors, therefore regulating epithelial cell growth and the rate of proliferation. These factors will drive the topical retinoids segment

This report provides an accurate prediction of the contribution of all the segments to the growth of the darier disease drugs market size and actionable market insights on the post-COVID-19 impact on each segment.

Darier Disease Drugs Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 4.6%
Market growth 2022-2026	$ 45.37 million
Market structure	Fragmented
YoY growth (%)	4.0
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 40%
Key consumer countries	US, Canada, Germany, UK, and China
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	AbbVie Inc., Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., BridgeBio Pharma Inc., Galderma SA, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Johnson and Johnson, Laminar Pharma, Mayne Pharma Group Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sawai Pharmaceutical Co. Ltd., Sigmapharm Laboratories LLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Tolmar Pharmaceuticals Inc., Validus Pharmaceuticals LLC, and Viatris Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Darier Disease Drugs Market Report?

CAGR of the market during the forecast period 2022-2026
Detailed information on factors that will drive darier disease drugs market growth during the next five years
Precise estimation of the darier disease drugs market size and its contribution to the parent market
Accurate predictions on upcoming trends and changes in consumer behavior
The growth of the darier disease drugs industry across North America, Europe, Asia, and Rest of World (ROW)
A thorough analysis of the market's competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of darier disease drugs market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 12: Market segments

3.3 Market size 2021

3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

4.2 Bargaining power of buyers
- Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

5.1 Market segments
- Exhibit 24: Chart on Product - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Product - Market share 2021-2026 (%)

5.2 Comparison by Product
- Exhibit 26: Chart on Comparison by Product
- Exhibit 27: Data Table on Comparison by Product

5.3 Topical retinoids - Market size and forecast 2021-2026
- Exhibit 28: Chart on Topical retinoids - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Topical retinoids - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Topical retinoids - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Topical retinoids - Year-over-year growth 2021-2026 (%)

5.4 Oral retinoids - Market size and forecast 2021-2026
- Exhibit 32: Chart on Oral retinoids - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Oral retinoids - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Oral retinoids - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Oral retinoids - Year-over-year growth 2021-2026 (%)

5.5 Others - Market size and forecast 2021-2026
- Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
- Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)

5.6 Market opportunity by Product
- Exhibit 40: Market opportunity by Product ($ million)

6 Customer Landscape

6.1 Customer landscape overview
- Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
- Exhibit 42: Chart on Market share by geography 2021-2026 (%)
- Exhibit 43: Data Table on Market share by geography 2021-2026 (%)

7.2 Geographic comparison
- Exhibit 44: Chart on Geographic comparison
- Exhibit 45: Data Table on Geographic comparison

7.3 North America - Market size and forecast 2021-2026
- Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)

7.4 Europe - Market size and forecast 2021-2026
- Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)

7.5 Asia - Market size and forecast 2021-2026
- Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)

7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

7.7 US - Market size and forecast 2021-2026
- Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)

7.8 Germany - Market size and forecast 2021-2026
- Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)

7.9 UK - Market size and forecast 2021-2026
- Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)

7.10 Canada - Market size and forecast 2021-2026
- Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)

7.11 China - Market size and forecast 2021-2026
- Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)

7.12 Market opportunity by geography
- Exhibit 82: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers

8.2 Market challenges

8.3 Impact of drivers and challenges
- Exhibit 83: Impact of drivers and challenges in 2021 and 2026

8.4 Market trends

9 Vendor Landscape

9.1 Overview

9.2 Vendor landscape
- Exhibit 84: Overview on Criticality of inputs and Factors of differentiation

9.3 Landscape disruption
- Exhibit 85: Overview on factors of disruption

9.4 Industry risks
- Exhibit 86: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
- Exhibit 87: Vendors covered

10.2 Market positioning of vendors
- Exhibit 88: Matrix on vendor position and classification

10.3 Bausch Health Companies Inc.
- Exhibit 89: Bausch Health Companies Inc. - Overview
- Exhibit 90: Bausch Health Companies Inc. - Business segments
- Exhibit 91: Bausch Health Companies Inc. - Key news
- Exhibit 92: Bausch Health Companies Inc. - Key offerings
- Exhibit 93: Bausch Health Companies Inc. - Segment focus

10.4 BridgeBio Pharma Inc.
- Exhibit 94: BridgeBio Pharma Inc. - Overview
- Exhibit 95: BridgeBio Pharma Inc. - Product / Service
- Exhibit 96: BridgeBio Pharma Inc. - Key offerings

10.5 Galderma SA
- Exhibit 97: Galderma SA - Overview
- Exhibit 98: Galderma SA - Product / Service
- Exhibit 99: Galderma SA - Key news
- Exhibit 100: Galderma SA - Key offerings

10.6 GlaxoSmithKline Plc
- Exhibit 101: GlaxoSmithKline Plc - Overview
- Exhibit 102: GlaxoSmithKline Plc - Business segments
- Exhibit 103: GlaxoSmithKline Plc - Key news
- Exhibit 104: GlaxoSmithKline Plc - Key offerings
- Exhibit 105: GlaxoSmithKline Plc - Segment focus

10.7 Glenmark Pharmaceuticals Ltd.
- Exhibit 106: Glenmark Pharmaceuticals Ltd. - Overview
- Exhibit 107: Glenmark Pharmaceuticals Ltd. - Product / Service
- Exhibit 108: Glenmark Pharmaceuticals Ltd. - Key offerings

10.8 Mayne Pharma Group Ltd.
- Exhibit 109: Mayne Pharma Group Ltd. - Overview
- Exhibit 110: Mayne Pharma Group Ltd. - Business segments
- Exhibit 111: Mayne Pharma Group Ltd. - Key news
- Exhibit 112: Mayne Pharma Group Ltd. - Key offerings
- Exhibit 113: Mayne Pharma Group Ltd. - Segment focus

10.9 Novartis AG
- Exhibit 114: Novartis AG - Overview
- Exhibit 115: Novartis AG - Business segments
- Exhibit 116: Novartis AG - Key offerings
- Exhibit 117: Novartis AG - Segment focus

10.10 Sigmapharm Laboratories LLC
- Exhibit 118: Sigmapharm Laboratories LLC - Overview
- Exhibit 119: Sigmapharm Laboratories LLC - Product / Service
- Exhibit 120: Sigmapharm Laboratories LLC - Key offerings

10.11 Sun Pharmaceutical Industries Ltd.
- Exhibit 121: Sun Pharmaceutical Industries Ltd. - Overview
- Exhibit 122: Sun Pharmaceutical Industries Ltd. - Product / Service
- Exhibit 123: Sun Pharmaceutical Industries Ltd. - Key offerings

10.12 Tolmar Pharmaceuticals Inc.
- Exhibit 124: Tolmar Pharmaceuticals Inc. - Overview
- Exhibit 125: Tolmar Pharmaceuticals Inc. - Product / Service
- Exhibit 126: Tolmar Pharmaceuticals Inc. - Key offerings

11 Appendix

11.1 Scope of the report

11.2 Inclusions and exclusions checklist
- Exhibit 127: Inclusions checklist
- Exhibit 128: Exclusions checklist

11.3 Currency conversion rates for US$
- Exhibit 129: Currency conversion rates for US$

11.4 Research methodology
- Exhibit 130: Research methodology
- Exhibit 131: Validation techniques employed for market sizing
- Exhibit 132: Information sources

11.5 List of abbreviations
- Exhibit 133: List of abbreviations

health: Includes veterinary drugs (excluded from the scope of the report)

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

darier disease drugs market market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis